Dallas, Texas (PRWEB) June 30, 2013
The Global Blood Industry Report provides:
- An overview of the structure and current market size of the global blood industry, including coverage of such segments as blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Blood usage patterns and trends
- Government and regulatory controls
- The impact of diseases on the blood industry - http://www.reportsnreports.com/reports/257435-the-global-blood-industry.html.
- Current product lines and examination of newly emerging products and technologies
- Newly issued patents relating to blood therapeutics, processing, screening, and collection technologies
- Comprehensive company profiles of major players in the industry.
Scope and Format
This study encompasses the wide range of products and services that comprise the global blood industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other select regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.
Corporate Profiles: Abbott Laboratories, Baxter International, Inc., Bayer Ag, Bio-Rad Laboratories, Inc., Csl Behring, Entegrion, Inc., Grifols International, S.A./Talecris, Haemonetics Corporation, Hologic Gen-Probe, Inc., Novo Nordisk A/S, Octapharma Ag, Omrix Biopharmaceuticals, Ltd., Pfizer, Inc., Roche Holding Ltd.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=257435.
Blood Banking: Granular Analysis of the US Market Supplier Shares, Forecasts for 40 Typing, Grouping, Screening Tests - http://www.reportsnreports.com/reports/254222-blood-banking-granular-analysis-of-the-us-market-supplier-shares-forecasts-for-40-typing-grouping-screening-tests.html
This new report, “Competing in the US Blood Banking Market,” including supplier shares, as well as test volume and sales forecasts for 40 typing, grouping and infectious disease screening tests. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers of blood banking products by country.
Market Segmentation Analysis
- Test volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment:
- Blood Centers
- Plasma Fractionation Facilities
- Commercial/Private Laboratories
- Military Blood Banks
Worldwide Market Overview
- Estimates of the facilities performing blood bank testing by country.
- Test volume and sales projections.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=254222.
Research and Development Trend of China Blood Products Industry, 2013 (http://www.reportsnreports.com/reports/255913-research-and-development-trend-of-china-blood-products-industry-2013.html) - At present, the demand in China’s blood products market is strong, but restricts by blood plasma supply and NDRC price limit, China’s blood products market has been developing steadily since 2005; in recent three years, this industry has maintained the growth rate of about 20%. Huidian Research estimated that the scale of China’s blood products market was CNY 17.28 billion in 2012.
The per capita blood products consumption of Chinese residents is extremely low, and there is a relatively large gap compares with the developed countries. China’s albumin supply has been tight, and the annual growth rate will be about 15% in the future. The per capita consumption of human immunoglobulin for intravenous injection is only 10% of the foreign countries, since 2004, the growth rate in this aspect has been maintaining at the level of more than 30%; at present, this application in small and medium-scale hospitals is still unpopular, and the development potential is relatively huge; as for the sales of coagulation factor products, China is still in its infancy, compares with foreign market share of 40%, China owns a broad market space.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=255913.
Blood Disease Treatment Drugs Markets in China (http://www.reportsnreports.com/reports/243004-blood-disease-treatment-drugs-markets-in-china.html) – Order By 31-Dec-2013 & Get 50% Discount on this report.
China's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
Explore more reports on Biotechnology Market @ http://www.reportsnreports.com/market-research/biotechnology/.
ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.